Clinical trial
A Study to Evaluate FK778 in Kidney Transplant Patients
NCT00189735 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00189735 |
|---|---|
| Title | A Study to Evaluate FK778 in Kidney Transplant Patients |
| Official title | A Multicentre, Randomised, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Different Concentrations of FK778 With Tacrolimus (FK506) and Steroids Versus a Standard Regimen of Tacrolimus, MMF and Steroids in Renal Transplant Patients |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Collaborators | Astellas Pharma Europe B.V. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Transplantation, Renal Transplantation, Transplantation, Renal, Kidney, Grafting |
| Intervention type | Drug |
| Interventions | FK778 |
| Enrollment | 364 |
| Start date | Sep 1, 2003 |
| Primary completion | Oct 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Sep 19, 2005 |
| Last update posted | Apr 17, 2008 |
| Countries | Austria, Belgium, Czechia, France, Germany, Italy, Netherlands, Poland, Spain, Sweden, Switzerland, United Kingdom |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: